Investigators Pave the Way for Next-Generation TB Vaccine

Investigators pave the way for next-generation TB vaccine

Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's leading cause of death from infectious disease, claiming more than 1.2 million lives each year. The single available vaccine protects young children from severe cases of TB but does little to prevent the spread of disease in adolescents and adults.

BIDMC Investigators Pave the Way for Next-Generation TB Vaccine

Scientists at Beth Israel Deaconess Medical Center (BIDMC) have created a new TB vaccine candidate with newly identified antigens and delivered by mRNA technology, the same approach that allowed the rapid development of safe and effective vaccines against COVID-19.